Syndia v. Gillette
This article was originally published in The Rose Sheet
Executive Summary
Gillette ordered to pay Syndia $10 mil. in damages June 14 by jury in Chicago federal court in patent infringement case. Gillette's "diamond-like carbon"-coated razor blades used in Mach3, Mach3 Turbo and Venus razors found to infringe patents owned by Syndia, Chicago company maintains. Damages and injunctive relief for any future infringement have yet to be determined, Syndia adds, noting it intends to file for injunctive relief "barring future sales of March3, Turbo and Venus." Gillette said the ruling will have no material impact on business and does not prevent the firm from manufacturing any of its blades or razors. "Gillette also is prepared to appeal this matter to the Federal Circuit Court of Appeals in Washington, D.C. if that should prove necessary," company adds...
You may also be interested in...
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.